Metaplastic breast carcinomas are enriched in markers of tumor-initiating cells and epithelial to mesenchymal transition

Modern Pathology

Volumn 25, Issue 2, 2012, Pages 178-184

  Zhang, Yanhong ^a,b   Toy, Kathy A ^a   Kleer, Celina G ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

aldehyde dehydrogenase; CCN6; E cadherin; epithelial to mesenchymal transition; metaplastic breast cancer; WISP3; ZEB

Indexed keywords

ALDEHYDE DEHYDROGENASE; ALDEHYDE DEHYDROGENASE ISOENZYME 1; BIOLOGICAL MARKER; CD24 ANTIGEN; HERMES ANTIGEN; UNCLASSIFIED DRUG; UVOMORULIN;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER INVASION; CELL SPECIFICITY; CLINICAL ARTICLE; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; FISHER EXACT TEST; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; METAPLASIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPINDLE CELL; UPREGULATION;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CADHERINS; CARCINOMA; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; METAPLASIA; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; NEOPLASTIC STEM CELLS; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 84856528891     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2011.167     Document Type: Article

References (39)

1. Tavassoli FA, Devilee P. Pathology and Genetics of Tumors of the Breast and Female Genital Organs. IARC Press: Lyon, 2003.
2. Reis-Filho JS, Milanezi F, Steele D, et al. Metaplastic breast carcinomas are basal-like tumours. Histopathology 2006;49:10-21. (Pubitemid 43972916)
3. Lacroix-Triki M, Geyer FC, Lambros MB, et al. betacatenin/Wnt signalling pathway in fibromatosis, metaplastic carcinomas and phyllodes tumours of the breast. Mod Pathol 2010;23:1438-1448.
4. Kumar V, Fausto N, Aster J. Robbins and Cotran Pathologic Basis of Disease 8th edn. Elsevier: Philadelphia, PA, 2010.
5. Hugo H, Ackland ML, Blick T, et al. Epithelial-mesenchymal and mesenchymal-epithelial transitions in carcinoma progression. J Cell Physiol 2007;213:374-383. (Pubitemid 47509716)
6. Peinado H, Olmeda D, Cano A. Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer 2007;7:415-428. (Pubitemid 46809165)
7. Zhou BP, Deng J, Xia W, et al. Dual regulation of Snail by GSK-3beta-mediated phosphorylation in control of epithelial-mesenchymal transition. Nat Cell Biol 2004;6:931-940. (Pubitemid 39359846)
8. Mani SA, Guo W, Liao MJ, et al. The epithelialmesenchymal transition generates cells with properties of stem cells. Cell 2008;133:704-715. (Pubitemid 351636299)
9. Blick T, Hugo H, Widodo E, et al. Epithelial mesenchymal transition traits in human breast cancer cell lines parallel the CD44(hi/)CD24 (lo/) stem cell phenotype in human breast cancer. J Mammary Gland Biol Neoplasia 2010;15:235-252.
10. Lorenzatti G, Huang W, Pal A, et al. CCN6 (WISP3) decreases ZEB1-mediated EMT and invasion by attenuation of IGF-1 receptor signaling in breast cancer. J Cell Sci 2011;124:1752-1758.
11. Aigner K, Dampier B, Descovich L, et al. The transcription factor ZEB1 (deltaEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity. Oncogene 2007;26:6979-6988. (Pubitemid 350014612)
12. Huang W, Zhang Y, Varambally S, et al. Inhibition of CCN6 (Wnt-1-induced signaling protein 3) downregulates E-cadherin in the breast epithelium through induction of snail and ZEB1. Am J Pathol 2008;172: 893-904. (Pubitemid 351519987)
13. Schmalhofer O, Brabletz S, Brabletz T. E-cadherin, beta-catenin, and ZEB1 in malignant progression of cancer. Cancer Metastasis Rev 2009;28:151-166.
14. Hennessy BT, Gonzalez-Angulo AM, Stemke-Hale K, et al. Characterization of a naturally occurring breast cancer subset enriched in epithelial-to- mesenchymal transition and stem cell characteristics. Cancer Res 2009;69:4116-4124.
15. Creighton CJ, Chang JC, Rosen JM. Epithelial-mesenchymal transition (EMT) in tumor-initiating cells and its clinical implications in breast cancer. J Mammary Gland Biol Neoplasia 2010;15:253-260.
16. Taube JH, Herschkowitz JI, Komurov K, et al. Core epithelial-to- mesenchymal transition interactome gene-expression signature is associated with claudinlow and metaplastic breast cancer subtypes. Proc Natl Acad Sci USA 2010;107:15449-15454.
17. Lien HC, Hsiao YH, Lin YS, et al. Molecular signatures of metaplastic carcinoma of the breast by large-scale transcriptional profiling: identification of genes potentially related to epithelial-mesenchymal transition. Oncogene 2007;26:7859-7871. (Pubitemid 350261788)
18. Singh M, Spoelstra NS, Jean A, et al. ZEB1 expression in type I vs type II endometrial cancers: a marker of aggressive disease. Mod Pathol 2008;21:912-923. (Pubitemid 351896667)
19. Kowalski PJ, Rubin MA, Kleer CG. E-cadherin expression in primary carcinomas of the breast and its distant metastases. Breast Cancer Res 2003;5: R217-R222.
20. Kunju LP, Cookingham C, Toy KA, et al. EZH2 and ALDH-1 mark breast epithelium at risk for breast cancer development. Mod Pathol 2011;24:786-793.
21. Al-Hajj M, Wicha MS, Benito-Hernandez A, et al. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 2003;100: 3983-3988. (Pubitemid 36418143)
22. Abraham BK, Fritz P, McClellan M, et al. Prevalence of CD44 +CD24-/low cells in breast cancer may not be associated with clinical outcome but may favor distant metastasis. Clin Cancer Res 2005;11:1154-1159. (Pubitemid 40175765)
23. van Deurzen CH, Lee AH, Gill MS, et al. Metaplastic breast carcinoma: tumour histogenesis or dedifferentiation? J Pathol 2011;224:434-437.
24. Teixeira MR, Qvist H, Bohler PJ, et al. Cytogenetic analysis shows that carcinosarcomas of the breast are of monoclonal origin. Genes Chromosomes Cancer 1998;22:145-151. (Pubitemid 28208807)
25. Geyer FC, Weigelt B, Natrajan R, et al. Molecular analysis reveals a genetic basis for the phenotypic diversity of metaplastic breast carcinomas. J Pathol 2010;220:562-573.
26. Rosen PP. Rosen's breast pathology In: Rosen PP (ed). Rosen's Breast Pathology Third edn. Lippincott Williams & Wilkins: Philadelphia, PA, 2008.
27. Eger A, Aigner K, Sonderegger S, et al. DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells. Oncogene 2005;24:2375-2385. (Pubitemid 40546696)
28. Graham TR, Zhau HE, Odero-Marah VA, et al. Insulinlike growth factor-I-dependent up-regulation of ZEB1 drives epithelial-to-mesenchymal transition in human prostate cancer cells. Cancer Res 2008;68:2479-2488. (Pubitemid 351521824)
29. Hayes MJ, Thomas D, Emmons A, et al. Genetic changes of Wnt pathway genes are common events in metaplastic carcinomas of the breast. Clin Cancer Res 2008;14:4038-4044.
30. Dontu G, Abdallah WM, Foley JM, et al. In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev 2003;17: 1253-1270. (Pubitemid 36583168)
31. Ginestier C, Hur MH, Charafe-Jauffret E, et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 2007;1:555-567. (Pubitemid 350056407)
32. Lester TR, Hunt KK, Nayeemuddin KM, Gonzalez-Angulo AM, Feig BW, et al. Metaplastic sarcomatoid carcinoma of the breast appears more aggressive than other triple receptor-negative breast cancers. Breast Cancer Res Treat 2011; e-pub ahead of print.
33. Carlson RW, Allred DC, Anderson BO, et al. Breast cancer. Clinical practice guidelines in oncology. J Natl Compr Canc Netw 2009;7:122-192.
34. Rayson D, Adjei AA, Suman VJ, et al. Metaplastic breast cancer: prognosis and response to systemic therapy. Ann Oncol 1999;10:413-419. (Pubitemid 29236418)
35. Oberman HA. Metaplastic carcinoma of the breast. A clinicopathologic study of 29 patients. Am J Surg Pathol 1987;11:918-929. (Pubitemid 18011643)
36. Hennessy BT, Giordano S, Broglio K, et al. Biphasic metaplastic sarcomatoid carcinoma of the breast. Ann Oncol 2006;17:605-613.
37. Kakarala M, Wicha MS. Implications of the cancer stem-cell hypothesis for breast cancer prevention and therapy. J Clin Oncol 2008;26:2813-2820.
38. Li X, Lewis MT, Huang J, et al. Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy. J Natl Cancer Inst 2008;100:672-679.
39. Korkaya H, Liu S,Wicha MS. Regulation of cancer stem cells by cytokine networks: attacking cancers inflammatory roots. Clin Cancer Res 2011;17:6125-6129.